Stereotactic radiotherapy yekenza yemapapu isingagone kuvhiyiwa

Share This Post

Stereotactic body radiation therapy

Stereotactic body radiation therapy (SBRT), inozivikanwawo se stereotactic ablative radiotherapy (SABR). Kubva payakashandiswa pakati pemakore ekuma1990, SBRT yakazvisiyanisa mukurapwa kwakanyanya kwemamota mazhinji nekuda kwehupamhi hwekudzora bundu, kushivirira kwakanaka kweakajairika tishu, nguva yekurarama kwenguva refu uye varwere vari nyore kwazvo. Gomarara rekutanga remapapu rave mubatsiri wehunyanzvi uhu. SBRT inoshanda yakaderera-chikamu isiri-invasive ablation kurapwa inogona kuitwa mukiriniki yekunze. Inowanzobatwa 1-5 nguva, kamwe chete pazuva kana mamwe mazuva ose.

Iyo EDGE radiosurgery system yakashandiswa naHenry Ford Hospital muUnited States chizvarwa cheSBRT. Ndiyo yakanyanya kutema-kumucheto isina-invasive tumarara kuchenesa tekinoroji kusvika nhasi. Inogona kupfupisa nguva yekurapa radiotherapy kenza yemapapu kusvika 10-15 maminitsi, uye kurapa yose inopedzwa mumazuva 5. . Varwere vazhinji vanogona kudzokera kuhupenyu hwemazuva ese vachangobva kurapwa.

SBRT yekenza yemapapu isingagoni kuvhiyiwa

RTOG 0236 ndiyo yekutanga yakawanda-center kiriniki yekudzidza muNorth America kurapa SBRT yekiriniki isingashande pakutanga. kenza yemapapu. Iyo RTOG 0236 yekiriniki yekudzidza yakatanga muna 2004 uye yakabata varwere makumi mashanu nevanomwe. Muna 57, varwere vakanyoreswa. Mhedzisiro yekiriniki yakanaka chaizvo: makore matatu ekutanga tumor control rate inosvika 2006%, uye chiyero chekupona i3%.

Kushandisa SBRT kugomarara remapapu rakavhiyiwa

Migumisiro yekurapa kweSBRT yekenza yemapapu isingashande inoratidza kuti inogona kunyatsobvisa bundu rekutanga, uye kushivirira kuri nani mune ino chikamu chevanhu vane njodzi huru. Tichifunga nezveizvi, mukana wekushandiswa kwayo muvarwere vane kenza yemapapu inoshanda yakagamuchira kutariswa. Mhedzisiro yekiriniki inoratidza kuti chero bedzi muyero wemwaranzi unonzwisisika uchipihwa, kurapwa kweSBRT kunogona kuwana mushonga wekurapa uri padyo neiyo yekuvhiya resection kana kunyange lobectomy.

Speed ​​​​yekumberi banga ndiyo yakanyanya kumberi SBRT kurapwa tekinoroji kusvika parizvino

The EDGE bundu noninvasive radiosurgery treatment system inzira yekurapa cancer yakatenderwa neUS FDA muna 2014. Ndiyo yakanyanya kushanda zvakanyanya bundu radiosurgery system. Zvakaoma kuita kuvhiyiwa kwemazuva ese pamamota akadai semamota emumusoro, kenza yemapapu, nemamota emuzongoza. , Chirwere cheropa uye mamwe mamota akasimba ane mhedzisiro yekurapa iyo inonetsa kuwana neyakajairwa kuvhiyiwa uye radiotherapy michina, uye ndiyo yakanakisa sarudzo kune varwere vegomarara kubvisa maronda emamota kusvika zvino.

Kubva muna Kubvumbi 2014, yekutanga pasi rose EDGE bundu noninvasive radiotherapy system yanga ichishanda muhurongwa hwese hweHenry Ford Hospital muUnited States. Yakarapa vanopfuura mazana mana evarwere vane bundu, uye chiyero chekugutsikana kwekurapa (Tumor Co ntrol Rate) yakakura kupfuura 400%. Uye hapana maitiro akaipa akaitika. Pakati pevarwere vebundu aya, mamota emuuropi (kusanganisira primary and metastatic brain tumors) aitora 95%, kenza yemapapu yaisvika 31%, spinal tumors inosvika 29%. mapundu emudumbu yakaverengerwa 9%, uye adrenal cancer yakaverengera 7%.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.
kenza

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.

Lutetium Lu 177 dotatate, kurapwa kwepasi, ichangobva kugamuchira mvumo kubva kuUS Food and Drug Administration (FDA) yevarwere vevana, zvichiratidza chiitiko chakakosha muvana oncology. Mvumo iyi inomiririra chiedza chetariro kuvana vari kurwisana neuroendocrine tumors (NETs), isingawanzowanikwi asi inonetsa yegomarara iro rinowanzoratidza kuti rinoshingirira pakurapa kwakajairika.

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.
Chirwere chechirwere

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.

"Nogapendekin Alfa Inbakicept-PMLN, chinyorwa che immunotherapy, chinoratidza vimbiso mukurapa gomarara redundira kana yasanganiswa neBCG therapy. Iyi nzira yekuvandudza yakanangana nemakaki egomarara uku ichisimudzira mhinduro ye immune system, ichiwedzera kushanda kwemishonga yechivanhu seBCG. Miedzo yemakiriniki inoratidza zvinokurudzira, zvichiratidza zvakavandudzwa mhedzisiro yemurwere uye kufambira mberi kunogona kuitika mukurapa kenza yedundira. Kuwirirana pakati peNogapendekin Alfa Inbakicept-PMLN neBCG kunozivisa nguva itsva mukurapa gomarara redundira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa